Literature DB >> 23813110

Intermediate uveitis: comparison between childhood-onset and adult-onset disease.

Maria Pia Paroli1, Irene Abicca, Alfredo Sapia, Simone Bruschi, Paola Pivetti Pezzi.   

Abstract

PURPOSE: To compare demographic and clinical data, systemic disease association, visual prognosis, and complications found in childhood and adult onset of intermediate uveitis (IU).
METHODS: Retrospective cohort study of 287 patients with IU: 122 (42.5%) children at onset (<16 years), 165 (57.5%) adults. The data were entered on a computer-based standardized data entry form for statistical analysis. Student t test was used regarding differences in means. To assess significance of differences in proportions, we used the χ2 test, but when the population in the subgroup was ≤ 5 patients, we used the Fisher exact test (p<0.05 were deemed to be statistically significant and as reported were not corrected for multiple testing and so should be viewed as nominal).
RESULTS: A total of 61% of childhood-onset cases occurred in boys (44% in the adult group), while adult onset was more common in women (56% vs 39%) (p = 0.004, odds ratio [OR] 2.06). Regardless of the onset age, IU was frequently bilateral and idiopathic. The most frequent complication was cystoid macular edema (27.5%, p = 0.469, OR 0.85), which was also the most frequent cause of visual loss. Optic disc edema was more prevalent in children (15.5% vs 9.2%; p = 0.027, OR 1.81), ocular hypertension in adults (15.6% vs 7.5%, p = 0.007, OR 0.44). A total of 25 patients had non-idiopathic IU. A total of 14 patients had multiple sclerosis.
CONCLUSIONS: Intermediate uveitis was mostly idiopathic and bilateral in both groups. Visual prognosis was good and it was not age-related. Childhood onset was more frequent in boys, adult onset in women. Endocrinal factors could be involved.

Entities:  

Mesh:

Year:  2013        PMID: 23813110     DOI: 10.5301/ejo.5000336

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  8 in total

Review 1.  The role of sex in uveitis and ocular inflammation.

Authors:  Ian Y L Yeung; Nicholas A Popp; Chi-Chao Chan
Journal:  Int Ophthalmol Clin       Date:  2015

2.  Uveitis associated with multiple sclerosis: complications and visual prognosis.

Authors:  Derya Kaya; Mahmut Kaya; Serkan Özakbaş; Egemen İdiman
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

3.  Clinical characteristics of intermediate uveitis in adult Turkish patients.

Authors:  Esra Kardes; Betül Ilkay Sezgin Akcay; Kansu Bozkurt; Cihan Unlu; Gurkan Erdogan; Gulunay Akcali
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

Review 4.  Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis.

Authors:  Pinar Cakar Ozdal; Nilufer Berker; Ilknur Tugal-Tutkun
Journal:  J Ophthalmic Vis Res       Date:  2015 Oct-Dec

5.  Association between intermediate uveitis and toxocariasis in the Korean population.

Authors:  Jin-Woo Kwon; Yoonseob Sim; Donghyun Jee
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

6.  Characterization of cyclitic membranes by ultrabiomicroscopy in patients with pars planitis.

Authors:  Luz Elena Concha Del Río; Gonzalo Alejandro Duarte González; Mariana Mayorquín Ruiz; Lourdes Arellanes-García
Journal:  J Ophthalmic Inflamm Infect       Date:  2020-01-27

7.  VASOPROLIFERATIVE TUMORS IN INTERMEDIATE UVEITIS.

Authors:  Francesco Pichi; Piergorgio Neri; Aniruddha Agarwal; Alessandro Invernizzi; Netan Choudhry; Radgonde Amer; Andrea Lembo; Paolo Nucci; Ian Thompson; H Nida Sen; Carol L Shields
Journal:  Retina       Date:  2020-09       Impact factor: 3.975

8.  Intermediate Uveitis Etiology, Complications, Treatment, and Outcomes in a Colombian Uveitis Referral Center.

Authors:  William Rojas-Carabali; Juliana Reyes-Guanes; Valeria Villabona-Martinez; Maria Alejandra Fonseca-Mora; Alejandra de-la-Torre
Journal:  Clin Ophthalmol       Date:  2021-06-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.